concept

DISEASE-ASSOCIATED MICROGLIA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DISEASE-ASSOCIATED MICROGLIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

370Connections
6Hypotheses
4Analyses
50Outgoing
50Incoming

Summary

DISEASE-ASSOCIATED MICROGLIA is a concept in neurodegeneration research. Key relationships include: activates, associated with, expressed in. Associated with Aging, Als, Alzheimer. Connected to 146 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info
NameDISEASE-ASSOCIATED MICROGLIA
SummaryPage for Disease-Associated Microglia
Key Genes/ProteinsTREM2, MICROGLIA, MYELIN
Related DiseasesNeurodegeneration, Alzheimer, NEURODEGENERATIVE DISEASES, Als, Aging

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Disease-Associated Microglia

cell · 1120 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

mechanism · 7227 words

neuroinflammation

mechanism · 5462 words

Microglial Cells — Cell Type Hierarchy

cell · 5150 words

TREM2 Mechanism Hub

mechanism · 5099 words

Pathway Diagram

graph TD
    DISEASE_ASSOCIATED_MICROGLIA["DISEASE-ASSOCIATED MICROGLIA"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"activates"| Ms["Ms"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"activates"| Tumor["Tumor"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"expressed in"| Inflammation["Inflammation"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"expressed in"| Alzheimer["Alzheimer"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"expressed in"| Aging["Aging"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"expressed in"| Tauopathy["Tauopathy"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"expressed in"| Dementia["Dementia"]
    DISEASE_ASSOCIATED_MICROGLIA -->|"target for"| Als["Als"]
    TREM2["TREM2"] -->|"regulates"| DISEASE_ASSOCIATED_MICROGLIA
    MICROGLIA["MICROGLIA"] -->|"activates"| DISEASE_ASSOCIATED_MICROGLIA
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| DISEASE_ASSOCIATED_MICROGLIA
    PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| DISEASE_ASSOCIATED_MICROGLIA
    CYTOKINES["CYTOKINES"] -->|"activates"| DISEASE_ASSOCIATED_MICROGLIA
    TNF["TNF"] -->|"activates"| DISEASE_ASSOCIATED_MICROGLIA
    TNFR1["TNFR1"] -->|"activates"| DISEASE_ASSOCIATED_MICROGLIA
    AGING["AGING"] -->|"expressed in"| DISEASE_ASSOCIATED_MICROGLIA
    BCL2["BCL2"] -->|"expressed in"| DISEASE_ASSOCIATED_MICROGLIA

Outgoing (250)

TargetRelationTypeStr
Neurodegenerationactivatesdisease0.95
Alzheimeractivatesdisease0.85
NEURODEGENERATIVE DISEASESimplicated_indisease0.80
MICROGLIAactivatesgene0.80
MICROGLIAassociated_withgene0.80

Incoming (120)

SourceRelationTypeStr
TREM2regulatesgene0.90
TREM2activatesgene0.80
NEURODEGENERATIONactivatesgene0.80
TAUactivatesgene0.80
CYTOKINESactivatesgene0.70

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro 0.662 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Pri 0.515 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
Disease-Associated Microglia Metabolic Reprogramming 0.502 neurodegeneration Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferrop 0.493 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Sub 0.491 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vul 0.485 Alzheimer's Disease Cell type vulnerability in Alzheimers Di

Mentioning Analyses (4)

Scientific analyses that reference this entity

TREM2 Therapeutic Strategy Post-INVOKE-2

neurodegeneration | 2026-04-06 | 0 hypotheses

Neuroinflammation and microglial priming in early Alzheimer's Disease

neurodegeneration | 2026-04-04 | 0 hypotheses

TREM2 agonism vs antagonism in DAM microglia

neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.486

TREM2 agonism vs antagonism in DAM microglia

neurodegeneration | 2026-04-01 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
FAK/SRC-JNK axis promotes ferroptosis via upregulating ACSL4 expression. [PMID:41862445] Qin J, Ma S, Wang J, Huang S, Luan J, He Cell death & disease 2026 0
Quercetin attenuates ox-LDL-induced endothelial injury by regulating ferroptosis [PMID:41902795] Gao C, Liu B, Zhang R, Tian J, Xin H Toxicology mechanisms and meth 2026 0
NEDD8 promotes the ferritinophagy and ferroptosis of neurons in ischemic stroke [PMID:41662890] Rao W, Huang Y, Li J, Chen Q, Sun J et a J Stroke Cerebrovasc Dis 2026 0
Inhibition of Ferroptosis in Prostatitis Model by Low Intensity Extracorporeal S [PMID:41714892] Lin D, Li K, Kuang W, Chen Z, Zhang M World J Mens Health 2026 0
Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mec [PMID:41763496] Che L, Zhu L, Zhou L, Zhou Y Biochim Biophys Acta Rev Cance 2026 0
B4GALT1 deficiency attenuates steatohepatitis by regulating the PPARγ/ACSL4 axis [PMID:41860570] Chien Y, Xia R, Zhou D, Ai Y, Wu L et al Hepatol Commun 2026 0
[The Chinese medicine Gandouling attenuates brain injury in hepatolenticular deg [PMID:41946579] Wu K, Wang N, Zhao D, Wei W, Zhang W et Zhejiang Da Xue Xue Bao Yi Xue 2026 0
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease lin [PMID:41498558] Singh P, Rath SL Journal of Alzheimer's disease 2026 0
Resveratrol Alleviates Intervertebral Disc Degeneration by Targeting NCOA4-Media [PMID:41873334] Song C, Wu X, Chen C, Shen B, He Y, Liu Drug design, development and t 2026 0
Pan-PPAR agonist bezafibrate alleviates psoriasis by suppressing LCN2-dependent [PMID:41662914] ["Xin R", "Zhang J", "Zhang Y", "Dai M", Free radical biology & medicin 2026 0
Acteoside alleviates sepsis-induced acute lung injury by activating the Nrf2 pat [PMID:41895086] Wang Y, Zhang W, Zhang M, Zhu Y, Wang W, Tissue & cell 2026 0
Ferroptosis and microglial polarization in retinal vein occlusion: pathological [PMID:41924362] Xu J, Sun M, Wang C, Ju P, Guan XD, Xie International journal of ophth 2026 0
Vitamin C inhibits ACSL4 to alleviate ferro-aging in primates. [PMID:41819088] Liu L, Zheng Z, You W, Yang P, Wen Y et Cell Metab 2026 0
LPCAT3 deficiency Drives phospholipid remodeling and mitochondrial oxidative dys [PMID:41951050] Shao G, Ye C, Sun C, Pan J, Lu L et al. J Adv Res 2026 0
Microglia, Trem2, and Neurodegeneration. [PMID:38769824] Shi Q, Gutierrez RA, Bhat MA Neuroscientist 2025 0
Melatonin Alleviates Erastin-Induced Cell Death by Inhibiting Ferroptosis and Am [PMID:40442550] Wongjaikam S, Siengdee P, Somnus A, Govi Neurotoxicity research 2025 0
Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzhei [PMID:40640358] Zhu L, Zhou T, Wu L, Zhu X, Chen L, Zhan Scientific reports 2025 0
Microbiota-derived lysophosphatidylcholine alleviates Alzheimer's disease pathol [PMID:39510074] ["Zha Xu", "Liu Xicheng", "Wei Mengping" Cell metabolism 2025 0
Upregulation of MAM by C99 disrupts ACSL4 activity and phospholipid homeostasis [PMID:41394684] Montesinos J, Yun TD, Salomón-Cruz ID, A bioRxiv : the preprint server 2025 0
Danggui Shaoyao San ameliorates Alzheimer's disease by regulating lipid metaboli [PMID:40271063] Gong K, Zhou S, Xiao L, Xu M, Zhou Y, Lu Frontiers in pharmacology 2025 0